David King-Stephens, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Neurelis
    Date added:
    06/05/2023
    Date updated:
    06/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    UCB
    Date added:
    06/05/2023
    Date updated:
    06/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Eisai
    Date added:
    06/05/2023
    Date updated:
    06/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    SK Lifesciences
    Date added:
    06/05/2023
    Date updated:
    06/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    SK Lifesciences
    Date added:
    06/05/2023
    Date updated:
    06/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    Neurelis
    Date added:
    06/05/2023
    Date updated:
    06/05/2023
  • Attribution:
    Self
    Type of financial relationship:
    Speaker
    Ineligible company:
    UCB
    Date added:
    06/05/2023
    Date updated:
    06/05/2023
Return to 0140_Sutter Neurosciences Grand Rounds_Insulo-opercular Epilepsy_Live